Skip to main content
. 2018 Jun 20;13(6):e0197876. doi: 10.1371/journal.pone.0197876

Fig 4. Multimeric analysis of von Willebrand factor (VWF) in low-resolution SDS-agarose gels in patients with type 2A VWD and some discrepancy.

Fig 4

VWF from platelet lysate (NPt), plasmas of a normal subject (NP), patients with type 2A VWD and a patient with VWD type 2A (IIA) used as a control 2A are shown. (a-b): Patients with discrepancy between ratios and multimeric analysis; (c-d): Patients re-classified as type 2A on the basis of the genetic study.